Mass Spec
News on mass spectrometry technology and applications in genetics, genomics, and molecular diagnostics.
Sera Prognostics' Revenues, Loss Tick up in Q2
The preterm-birth diagnostics company, which went public in July, posted revenues of $20,000, up from $6,000 in the year-ago period.
Stanford Team Developing Metabolomic Technique to Detect Influzenza, Other Respiratory Viruses
Premium
Viruses can induce metabolite alterations that can be detected and allow for diagnosis of different infections, potentially including SARS-CoV-2.
InterVenn Biosciences Using New Funding to Develop Glycoproteomic Immunotherapy Response Assay
Premium
The company is building a blood-based glycoproteomic assay intended to help doctors predict which cancer patients will respond to checkpoint inhibitors.
InterVenn Biosciences Closes $201M Series C Round
The company said it planned to use the funds for the development of a liquid biopsy assay for predicting patient response to immune checkpoint inhibitors.
U of Texas, Baylor Team Shows Mass Spec-Based Device Effective at Identifying Cancer Surgery Margins
Premium
The researchers, who have launched a company, Genio Technologies, to commercialize the device, published data on its use in pancreatic cancer surgery.